Device manufacturer, as written on reports
Bayer Healthcare: medical device reports filed with FDA
11,031 reports name it as the manufacturer of the device involved, 2003–2026.
- 11,031
- reports naming it as manufacturer
- 0% of all MAUDE reports
- 15
- reports, 12 months to August 2026
- 20 in the 12 months before
- 76.6%
- classified as malfunction
- 62.3% across all reports
- 0.1%
- classified as death, as reported
- 0.9% across all reports
11,031 medical device reports received by FDA give Bayer Healthcare as the manufacturer of the device involved, 0% of the MAUDE database, from February 2003 to July 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
15 reports arrived in the 12 months to August 2026, down 25% from 20 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (76.6%), injury (22.9%) and other (0.3%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Contour Test Strips 50 | System, test, blood glucose, over the counter | 2,016 | 0 | 0% |
| Contour | System, test, blood glucose, over the counter | 1,563 | 38 | 0% |
| Essure | Transcervical contraceptive tubal occlusion device | 1,373 | 435 | 0.2% |
| Ascensia Contour | System, test, blood glucose, over the counter | 981 | 0 | 0.1% |
| Contour Test Strips | System, test, blood glucose, over the counter | 716 | 0 | 0% |
| Contour Next | System, test, blood glucose, over the counter | 587 | 33 | 0% |
| Breeze2 | System, test, blood glucose, over the counter | 429 | 0 | 0% |
| Contour Test Strips 10 | System, test, blood glucose, over the counter | 215 | 0 | 0% |
| Ascensia Breeze | Glucose oxidase, glucose | 194 | 0 | 0.5% |
| Ascensia Elite Xl | System, test, blood glucose, over the counter | 167 | 0 | 0% |
| Autodisc 50 Test Strips | System, test, blood glucose, over the counter | 151 | 0 | 0% |
| Glucometer Dex | Hexokinase, glucose | 145 | 0 | 0% |
| Contour Ts | System, test, blood glucose, over the counter | 117 | 0 | 0% |
| Glucometer Elite 4 Date | System, test, blood glucose, over the counter | 109 | 0 | 0% |
| Contour Next Link | System, test, blood glucose, over the counter | 88 | 0 | 0% |
| Contour Next EZ | System, test, blood glucose, over the counter | 52 | 6 | 0% |
| Glucometer Elite 4 Basic | System, test, blood glucose, over the counter | 29 | 0 | 0.8% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| NBW | System, test, blood glucose, over the counter | 8,825 | 80% |
| HHS | Transcervical contraceptive tubal occlusion device | 1,413 | 12.8% |
| CFR | Hexokinase, glucose | 181 | 1.6% |
| LFR | Glucose dehydrogenase, glucose | 179 | 1.6% |
| CGA | Glucose oxidase, glucose | 143 | 1.3% |
| FMK | Single use only blood lancet with an integral sharps injury prevention feature | 80 | 0.7% |
| KNH | Laparoscopic contraceptive tubal occlusion device | 68 | 0.6% |
| LCP | Assay, glycosylated hemoglobin | 51 | 0.5% |
| JJX | Single (specified) analyte controls (assayed and unassayed) | 48 | 0.4% |
| JJE | Analyzer, chemistry (photometric, discrete), for clinical use | 9 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Bayer Healthcare reports
How many FDA device reports name Bayer Healthcare as manufacturer?
11,031 reports through August 2026, 15 of them in the latest 12 months.
Which of its brands appear most often?
Contour Test Strips 50 (2,016), Contour (1,563), Essure (1,373), Ascensia Contour (981) and Contour Test Strips (716).
Which device types does it report on?
system, test, blood glucose, over the counter (80%), transcervical contraceptive tubal occlusion device (12.8%), hexokinase, glucose (1.6%) and glucose dehydrogenase, glucose (1.6%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.